Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Microtest Diagnostics provides automated multiplex in vitro diagnostic tests for allergies, influenza, autoimmune, and infectious Disease.
Andrea Crisanti: Chief Scientific Officer
Enrique Posner: DirectorPast Role: Kaleidos, Founder
About the Company
Microtest Diagnostics was spun out of London’s Imperial College in 2002 with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&D investment, Microtest Diagnostics recently CE-marked
the ADAM™ instrument.
The company operates with a highly skilled team of trained professionals with expertise across numerous fields including product, software and hardware design, instrument and assay development, regulatory approvals and quality control.
Our facilities are certified ISO13485:2003 Medical devices and ISO 9001:2008 for the design and development of microarray test devices.
